Retatrutide and trizepatide are a novel class of medications that bind to both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. These dual receptor agonists exhibit https://emilieakds258070.blogitright.com/38995840/recent-glp-1-and-gip-receptor-agonists-retatrutide-and-trizepatide